EUVIMEDEUVIMED entdecken
Crossref

Discovery of Sophoridine α-Aryl Propionamide Derivative ZM600 as a Novel Antihepatic Fibrosis Agent

Guoqing Li iD, Juanni Lu, Chuanhao Wang, Xuliang Chang, Zhuo Qu, Wannian Zhang, Chunlin Zhuang iD, Zhenyuan Miao iD, Weiheng Xu iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Guoqing Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Second Military Medical University, Shanghai 200433, P. R. China. Hauptthemen laut MEDLINE: Quinolizines, Liver Cirrhosis, Hepatic Stellate Cells, Alkaloids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, Shanghai Municipal Health Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic stellate cells (HSCs) activation is a key event in the development of liver fibrosis, and blockage of the activation of HSCs has been shown to alleviate liver fibrosis. Sophoridine, a bioactive alkaloid found in many Chinese herbs, exhibits a broad spectrum of pharmacological effects, but its activities are not strong. In this study, a series of structurally modified derivatives of sophoridine were designed and synthesized. Among them, sophoridine α-aryl propionamide derivative ZM600 displayed a significant inhibitory effect on the activation of HSCs. The in vivo experiment demonstrated that ZM600 markedly ameliorated carbon tetrachloride (CCl4) and bile duct ligation (BDL)-induced liver fibrosis with a significant improvement of extracellular matrix deposition. Mechanism investigations revealed that ZM600 specifically inhibited the activation of NF-κB, PI-3K/AKT, and TGF-β/Smads signaling pathways. These results suggest that ZM600 has a protective effect on liver fibrosis, which provides a new candidate for the treatment of liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolizinesLiver CirrhosisHepatic Stellate CellsAlkaloidsMatrinesAnimalsMaleNF-kappa BSignal TransductionCarbon TetrachlorideMiceStructure-Activity RelationshipRatsTransforming Growth Factor betaProto-Oncogene Proteins c-aktDrug DiscoveryAntifibrotic AgentsRats, Sprague-Dawley

Substanzen

QuinolizinesAlkaloidsMatrinesNF-kappa BCarbon TetrachlorideTransforming Growth Factor betaProto-Oncogene Proteins c-aktAntifibrotic Agents

Autor:innen und Institutionen

  • School of Pharmacy, Second Military Medical University, Shanghai 200433, P. R. China.
  • School of Pharmacy, Ningxia Medical University, Yinchuan 750004, P. R. China.
  • School of Chemistry and Chemical Engineering, Nanjing University of Science and Technology, Nanjing 210094, P. R. China.

ORCID-Profile: Guoqing Li, Chunlin Zhuang, Zhenyuan Miao, Weiheng Xu

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Li, G., Lu, J., Wang, C., Chang, X., Qu, Z., Zhang, W., Zhuang, C., Miao, Z., & Xu, W. (2024). Discovery of Sophoridine α-Aryl Propionamide Derivative ZM600 as a Novel Antihepatic Fibrosis Agent. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01010

Vancouver

Li G, Lu J, Wang C, Chang X, Qu Z, Zhang W, et al. Discovery of Sophoridine α-Aryl Propionamide Derivative ZM600 as a Novel Antihepatic Fibrosis Agent. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01010

BibTeX
@article{Li2024,
  author = {Li, Guoqing and Lu, Juanni and Wang, Chuanhao and Chang, Xuliang and Qu, Zhuo and Zhang, Wannian and Zhuang, Chunlin and Miao, Zhenyuan and Xu, Weiheng},
  title = {Discovery of Sophoridine α-Aryl Propionamide Derivative ZM600 as a Novel Antihepatic Fibrosis Agent},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01010}
}
Kostenlos starten →